U.S. Catheter Securement Device Market Size, Share & Forecast 2026–2032
Report Highlights
- ✓Country: United States
- ✓Market: Catheter Securement Devices
- ✓Market Size 2024: USD 412 million
- ✓Market Size 2032: USD 647 million
- ✓CAGR: 5.8%
- ✓Base Year: 2025
- ✓Forecast Period: 2026–2032
Analyst Recommendation — Enter Through Home Infusion Now: Medical device suppliers should secure home infusion pharmacy contracts with Option Care Health before the 2026 Medicare reimbursement cycle closes. Lead with sutureless, chlorhexidine-coated designs carrying 510(k) clearance, because home infusion holds the fastest PICC volume growth nationally.
Catheter Securement Devices in the U.S.: Market Overview
The U.S. catheter securement device market is valued at USD 412 million in 2024 and represents roughly 38 percent of global securement revenue, making it the largest single national market. Demand is anchored in acute care, where more than 5,000 U.S. hospitals insert central venous and peripherally inserted catheters daily. Unlike Europe, where national tenders dominate, U.S. purchasing flows through group purchasing organizations such as Vizient and Premier, which shape pricing across thousands of facilities.
Structurally, the market splits between hospital-grade sutured and sutureless devices and outpatient adhesive products. Becton Dickinson's Statlock line and Venetec's SecurAcath remain established reference designs, while 3M's Tegaderm CHG dressing has pushed into securement through integrated dressing-plus-anchor designs. Most devices are Class II products cleared through the FDA 510(k) pathway, which keeps entry moderate but requires clinical equivalence data for each new variant. Hospitals rarely switch once a standard is embedded in nursing protocols.
Growth Drivers in U.S. Catheter Securement
Three country-specific forces lift demand. First, CMS Hospital-Acquired Condition reduction programs penalize catheter-related bloodstream infections, prompting facilities to adopt securement that reduces catheter movement and dressing disruption. Second, the U.S. population aged 65 and over reached roughly 58 million in 2022 according to Census Bureau estimates, driving longer-term PICC and midline use. Third, Medicare coverage of home infusion therapy under Part B sustains outpatient catheter volumes.
Home infusion has become the fastest-growing use case. The Medicare Home Infusion Therapy services benefit, effective January 2021, created a reimbursable professional fee for nursing visits, which pushed infusion pharmacies such as Option Care Health to expand PICC and midline volumes. Securement is a required element of each home line, and every line change or dressing replacement consumes securement inventory, giving the segment repeat purchase economics that acute care lacks.
Market Restraints and Entry Barriers in the U.S.
The Federal Food, Drug, and Cosmetic Act requires a 510(k) premarket notification for each new securement variant, and FDA review times often extend past 90 days when predicate comparisons are contested. The revised Quality Management System Regulation under 21 CFR Part 820, aligned with ISO 13485 from February 2026, adds documentation burden for small suppliers. Group purchasing organizations negotiate multi-year contracts that lock in incumbents, so new entrants typically accept lower initial margins.
Pricing pressure compounds regulatory friction. Hospitals treat securement as commodity consumables, so per-unit prices for sutureless devices have fallen under value analysis committee review, which evaluates products against nursing time and infection data. Distribution is also fragmented: Cardinal Health and Medline control most hospital med-surg distribution, meaning manufacturers without their own sales forces face delayed access to end-user accounts.
Near-Term Entry Opportunities in U.S. Catheter Securement
The clearest near-term opportunity is home infusion PICC securement, an addressable pool estimated at USD 95 million in 2024 across roughly 1,100 licensed infusion pharmacies. Chlorhexidine-impregnated, sutureless devices that combine securement and antimicrobial dressing functions command premiums of 20 to 30 percent over standard adhesive anchors. Ambulatory infusion centers represent a second channel with lower group purchasing exposure.
Ambulatory surgery centers and dialysis facilities offer a second pathway with weaker GPO lock-in. Outpatient surgical volume in the United States exceeds 30 million procedures annually, and independent ASCs typically buy through regional distributors rather than national contracts. Veterans Affairs medical centers, procuring through the Federal Supply Schedule, present a third channel with fixed multi-year pricing that rewards suppliers able to meet VA sourcing requirements.
Market at a Glance
| Metric | U.S. Catheter Securement Devices |
|---|---|
| Market Size 2024 | USD 412 million |
| Market Size 2032 | USD 647 million |
| Growth Rate (CAGR) | 5.8% |
| Most Critical Decision Factor | GPO contract access and 510(k) clearance timelines |
| Largest Region | South Region |
| Competitive Structure | Concentrated among top med-surg suppliers, fragmented specialists |
Leading Market Participants
- Becton Dickinson
- ICU Medical
- Teleflex
- Medline Industries
- Cardinal Health
- B. Braun Medical
- Avanos Medical
- 3M
- Venetec International
- Medtronic
Regulatory and Policy Environment in the U.S.
FDA oversight of catheter securement devices runs through the Center for Devices and Radiological Health under the Federal Food, Drug, and Cosmetic Act. Most products require 510(k) clearance, while the Quality Management System Regulation under 21 CFR Part 820 transitions to ISO 13485 alignment effective February 2, 2026, requiring manufacturers to update design controls and supplier audits within that window. Biocompatibility testing follows ISO 10993 standards, and Medical Device User Fee Amendments fee schedules apply to each submission.
Reimbursement and infection policy shape purchasing. The CMS Hospital-Acquired Condition Reduction Program penalizes hospitals with elevated CLABSI rates, and reporting flows through the CDC National Healthcare Safety Network. The Medicare Physician Fee Schedule and the Part B home infusion benefit, administered by CMS, set compensation for nursing visits rather than devices. Compliance preparation for the 2026 QMSR transition must be completed before the next CMS rule cycle begins.
Outlook for U.S. Catheter Securement Devices to 2032
By 2032 the U.S. market is forecast to reach USD 647 million at a 5.8 percent CAGR from the 2025 base year. Growth will concentrate in home infusion and ambulatory settings, where sutureless and antimicrobial designs will represent a majority of unit volume, displacing sutured hospital standards. Acute-care revenue will grow more slowly as dressing-integrated products absorb standalone securement spend.
Consolidation will reshape supply. Larger med-surg suppliers such as Medline and Cardinal Health will continue acquiring mid-sized securement specialists and integrating securement into bundled procedure kits. Manufacturers that maintain ISO 13485 certified supply and rapid 510(k) turnaround will hold the advantage, while single-product entrants without distribution access will face margin compression through 2032.
Frequently Asked Questions
Market Segmentation
- Sutured Securement Devices
- Sutureless Adhesive Securement Devices
- Chlorhexidine-Impregnated Securement Dressings
- Integrated Securement Dressings
- Bridge Securement Devices
- Acute Care Hospitals
- Home Infusion Pharmacies
- Ambulatory Surgery Centers
- Dialysis Facilities
- Veterans Affairs Medical Centers
- Group Purchasing Organizations
- Med-Surg Distributors
- Direct Sales Force
- Federal Supply Schedule
- Online Medical Supply Platforms
Table of Contents
Research Framework and Methodological Approach
Information
Procurement
Information
Analysis
Market Formulation
& Validation
Overview of Our Research Process
MarketsNXT follows a structured, multi-stage research framework designed to ensure accuracy, reliability, and strategic relevance of every published study. Our methodology integrates globally accepted research standards with industry best practices in data collection, modeling, verification, and insight generation.
1. Data Acquisition Strategy
Robust data collection is the foundation of our analytical process. MarketsNXT employs a layered sourcing model.
- Company annual reports & SEC filings
- Industry association publications
- Technical journals & white papers
- Government databases (World Bank, OECD)
- Paid commercial databases
- KOL Interviews (CEOs, Marketing Heads)
- Surveys with industry participants
- Distributor & supplier discussions
- End-user feedback loops
- Questionnaires for gap analysis
Analytical Modeling and Insight Development
After collection, datasets are processed and interpreted using multiple analytical techniques to identify baseline market values, demand patterns, growth drivers, constraints, and opportunity clusters.
2. Market Estimation Techniques
MarketsNXT applies multiple estimation pathways to strengthen forecast accuracy.
Bottom-up Approach
Aggregating granular demand data from country level to derive global figures.
Top-down Approach
Breaking down the parent industry market to identify the target serviceable market.
Supply Chain Anchored Forecasting
MarketsNXT integrates value chain intelligence into its forecasting structure to ensure commercial realism and operational alignment.
Supply-Side Evaluation
Revenue and capacity estimates are developed through company financial reviews, product portfolio mapping, benchmarking of competitive positioning, and commercialization tracking.
3. Market Engineering & Validation
Market engineering involves the triangulation of data from multiple sources to minimize errors.
Extensive gathering of raw data.
Statistical regression & trend analysis.
Cross-verification with experts.
Publication of market study.
Client-Centric Research Delivery
MarketsNXT positions research delivery as a collaborative engagement rather than a static information transfer. Analysts work with clients to clarify objectives, interpret findings, and connect insights to strategic decisions.